000 01358 a2200337 4500
005 20250518023940.0
264 0 _c20190808
008 201908s 0 0 eng d
022 _a1950-6007
024 7 _a10.1016/j.biopha.2019.108670
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRehman, Kanwal
245 0 0 _aGenistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses.
_h[electronic resource]
260 _bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_cApr 2019
300 _a108670 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBlood Glucose
_xdrug effects
650 0 4 _aDiabetes Mellitus, Experimental
_xdrug therapy
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aGenistein
_xpharmacology
650 0 4 _aGlucagon-Like Peptide 1
_xmetabolism
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aInflammation Mediators
_xantagonists & inhibitors
650 0 4 _aInsulin Resistance
_xphysiology
650 0 4 _aRats
700 1 _aAli, Mehwish Bagh
700 1 _aAkash, Muhammad Sajid Hamid
773 0 _tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_gvol. 112
_gp. 108670
856 4 0 _uhttps://doi.org/10.1016/j.biopha.2019.108670
_zAvailable from publisher's website
999 _c29393035
_d29393035